
Press Releases
Blood-based Biomarker For Alzheimer’s Disease Diagnostics Market Valuation, ROI Potential 2026–2036
In a landscape where the global burden of Alzheimer’s disease continues to escalate, the emergence of blood-based biomarkers is heralding a new era of accessible,